Evidence map›Paper›PMID 41749782›Full record

ArticleBioengineering (Basel, Switzerland)2026

Divergent Myelination or Divergent Trajectories? Insights from MPF Mapping in Bipolar Disorder and Recurrent Depressive Disorder.

Remigiusz Recław, Anna Grzywacz

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Remigiusz RecławIndependent Laboratory of Genetics and Behavioral Epigenetics, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Street, 70-111 Szczecin, Poland.ORCID 0009-0004-7841-821X
Anna GrzywaczIndependent Laboratory of Genetics and Behavioral Epigenetics, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Street, 70-111 Szczecin, Poland.ORCID 0000-0002-2633-520X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantitative magnetic resonance imaging has increasingly highlighted white matter abnormalities as a key component of affective disorders. Fast macromolecular proton fraction (MPF) mapping, a myelin-sensitive technique, recently revealed divergent patterns of white matter myelination in bipolar disorder (BD) and recurrent depressive disorder (RDD), with reduced MPF in RDD but elevated MPF in BD. These findings challenge uniform hypomyelination models of mood disorders. In this Communication, we propose a trajectory-oriented reinterpretation of these results, suggesting that MPF differences may reflect distinct neurodevelopmental and lifespan-related myelination trajectories rather than a simple marker of tissue damage. Elevated MPF in BD-observed particularly in relatively young patients-may indicate accelerated or dysregulated white matter maturation or activity-dependent myelin plasticity, whereas reduced MPF in RDD may reflect impaired maintenance of myelin integrity. We emphasize that MPF should not be interpreted as a unidirectional index of pathology and argue that it may serve as a phenotype-differentiating biomarker between BD and RDD, warranting further longitudinal and multimodal studies.

Indexed as

bipolar disordermacromolecular proton fractionmyelinationquantitative MRIrecurrent depressive disorderwhite matter

Identifiers

PMID41749782
PMCPMC12937745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.